Panic Disorder – Epidemiology – Mature Markets Data

Clarivate Epidemiology’s coverage of panic disorder comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of panic disorder for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered.

Clarivate Epidemiology’s panic disorder forecast will answer the following question:

  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of panic disorder over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.

In addition to the total number of prevalent cases for each forecast year, Clarivate Epidemiology provides at least ten years of forecast data for the following subpopulations of panic disorder:

  • Total prevalent cases by comorbid mood disorder.
  • Total prevalent cases by any comorbid anxiety disorder.
  • Total prevalent cases by comorbid impulse-control disorder.
  • Total prevalent cases by any comorbid mental disorder.
  • Total incident cases
  • Lifetime DALYs gained

Note: Coverage may vary by country.

Table of contents

  • Panic Disorder - Epidemiology - Mature Markets Data
    • Introduction
      • Key Findings
        • Key Updates
      • Total 12-Month Prevalence of Panic Disorder per 1,000 People Aged 15+ in 2021 and 2041ttttttttt
      • Relative Sizes of the Factors Contributing to the Trend in Total 12-Month Prevalent Cases of Panic Disorder Over the Next 20 Years
    • Epidemiology Data
    • Methods
      • Total 12-Month Prevalent Cases
      • Comorbidities
      • Total Incident Cases Based on DSM-5
      • Lifetime DALYs Gained
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Panic Disorder
        • Studies Excluded from the Analysis of Panic Disorder
      • Risk/Protective Factors
        • Risk/Protective Factors for Panic Disorder
      • Bibliography
      • Glossary